Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synovial tissue analysis in clinical trials.

Barry Bresnihan1, Dominique Baeten, Gary S Firestein

  • 1Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland. c.walsh@st-vincents.ie

The Journal of Rheumatology
|December 7, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulatory microRNA signature distinguishing rheumatoid arthritis and psoriatic arthritis.

Rheumatology (Oxford, England)·2026
Same author

JAK/STAT inhibition reprograms T cell activation and metabolism in inflammatory arthritis patients.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

RA and PsA synovial tissue single-cell analysis demonstrates differential fibroblast populations with distinct phenotypes and functional capacities.

Annals of the rheumatic diseases·2026
Same author

Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints.

Nature immunology·2026
Same author

Immune cell-derived cytokines synergistically interact to drive synovial fibroblast invasive function and metabolic capacity.

Journal of autoimmunity·2025
Same author

Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.

Clinical and experimental rheumatology·2025

Synovial tissue analysis shows promise for rheumatoid arthritis clinical trials. Evaluating changes in the synovial membrane can reveal early treatment effects, aiding in developing new therapies.

Area of Science:

  • Rheumatology and clinical trial methodology.
  • Inflammation and joint disease research.

Background:

  • The synovial membrane is a key target in treating rheumatoid arthritis and related conditions.
  • Controlling synovitis is crucial for managing symptoms, preventing joint damage, and maintaining function.
  • Synovial tissue analysis offers a potential endpoint for clinical trials.

Purpose of the Study:

  • To establish evidence for synovial tissue analysis as a valid endpoint in randomized controlled trials (RCTs).
  • To determine if evaluating synovial tissue changes can identify early therapeutic effects in arthropathies.

Main Methods:

  • Systematic evaluation of synovial tissue changes in patients undergoing treatment.
  • Focus on utilizing this analysis within the framework of RCTs.

Related Experiment Videos

  • Working towards meeting the Outcome Measures in Rheumatology (OMERACT) filter criteria.

    • Main Results:

    • Synovial tissue analysis has considerable potential for future randomized controlled trials (RCTs).
    • Early therapeutic effects can be identified by evaluating synovial tissue changes.
    • This method may allow for the use of relatively small patient numbers in RCTs.

    Conclusions:

    • Synovial tissue analysis is a valuable tool for assessing treatment efficacy in arthropathies.
    • Further evidence is being established to validate synovial tissue analysis as an OMERACT-endorsed endpoint.
    • This approach can enhance the efficiency and sensitivity of clinical trials for inflammatory joint diseases.